Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial

Title
Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
Authors
Keywords
Gemcitabine, Pancreatic Ductal Adenocarcinoma, Relative Dose Intensity, Macroscopic Residual Tumor, Waterfall Plot
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 20, Issue 12, Pages 3794-3801
Publisher
Springer Nature
Online
2013-07-10
DOI
10.1245/s10434-013-3129-9

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search